Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CME GROUP INC.CME · Entity 2909 | Director | June 25, 2026 | June 29, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CME GROUP INC.
Report date June 25, 2026 · Filed June 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock Class ASEC Table I · non-derivative | Direct | 25,644 |
Reported balance
After 2026-06-25 transaction · row 1
1 source rowRow 1 · 2026-06-25 · Grant · Acquired 645 · Balance 25,644 F1: Represents a grant of fully vested shares of Class A Common Stock issued to the Reporting Person as part of the Issuer's annual equity compensation program for non-employee directors under the CME Group Director Stock Plan. These shares are not subject to any vesting conditions. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a grant of fully vested shares of Class A Common Stock issued to the Reporting Person as part of the Issuer's annual equity compensation program for non-employee directors under the CME Group Director Stock Plan. These shares are not subject to any vesting conditions.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 25, 2026 Filed Jun 29, 2026 20:30 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 645 | $225.00 | $145,125.00 |
DisclosureSEC source: 0001212813-26-000003 · wk-form4_1782765002.xml · nonDerivative · entry 1 GEPSMAN MARTIN J · CIK 0001212813 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,644 F1 · kind: Represents a grant of fully vested shares of Class A Common Stock issued to the Reporting Person as part of the Issuer's annual equity compensation program for non-employee directors under the CME Group Director Stock Plan. These shares are not subject to any vesting conditions. Read SEC document |
| February 20, 2026 Filed Feb 20, 2026 19:07 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 300 | $305.90 | $91,770.00 |
DisclosureSEC source: 0001628280-26-010122 · wk-form4_1771614454.xml · nonDerivative · entry 1 GEPSMAN MARTIN J · CIK 0001212813 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,999 Read SEC document |
| June 25, 2025 Filed Jun 26, 2025 22:34 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 532 | $273.03 | $145,251.96 |
DisclosureSEC source: 0001156375-25-000161 · wk-form4_1750977242.xml · nonDerivative · entry 1 GEPSMAN MARTIN J · CIK 0001212813 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,299 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| May 15, 2025 Filed May 19, 2025 13:08 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 300 | $273.17 | $81,951.00 |
DisclosureSEC source: 0001156375-25-000126 · wk-form4_1747660112.xml · nonDerivative · entry 1 GEPSMAN MARTIN J · CIK 0001212813 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,767 Read SEC document |
| November 04, 2024 Filed Nov 5, 2024 01:05 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 400 | $222.92 | $89,168.00 |
DisclosureSEC source: 0001156375-24-000196 · wk-form4_1730768734.xml · nonDerivative · entry 1 GEPSMAN MARTIN J · CIK 0001212813 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,067 Read SEC document |
| June 25, 2024 Filed Jun 27, 2024 00:47 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 748 | $194.10 | $145,186.80 |
DisclosureSEC source: 0001156375-24-000126 · wk-form4_1719449216.xml · nonDerivative · entry 1 GEPSMAN MARTIN J · CIK 0001212813 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,467 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| October 26, 2023 Filed Oct 26, 2023 18:53 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 300 | $216.33 | $64,899.00 |
DisclosureSEC source: 0001156375-23-000176 · wk-form4_1698346411.xml · nonDerivative · entry 1 GEPSMAN MARTIN J · CIK 0001212813 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,719 Read SEC document |
| June 26, 2023 Filed Jun 28, 2023 16:14 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 811 | $178.89 | $145,079.79 |
DisclosureSEC source: 0001156375-23-000095 · wf-form4_168796887533240.xml · nonDerivative · entry 1 GEPSMAN MARTIN J · CIK 0001212813 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,019 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 27, 2022 Filed Jun 29, 2022 14:34 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 693 | $209.44 | $145,141.92 |
DisclosureSEC source: 0001156375-22-000206 · wf-form4_165651328107838.xml · nonDerivative · entry 1 GEPSMAN MARTIN J · CIK 0001212813 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,208 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| January 25, 2022 Filed Jan 26, 2022 20:21 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 47 | $221.79 | $10,424.13 |
DisclosureSEC source: 0001156375-22-000028 · wf-form4_164322848692653.xml · nonDerivative · entry 1 GEPSMAN MARTIN J · CIK 0001212813 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,515 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| December 07, 2021 Filed Dec 9, 2021 13:59 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 500 | $231.00 | $115,500.00 |
DisclosureSEC source: 0001156375-21-000189 · wf-form4_163905836601624.xml · nonDerivative · entry 1 GEPSMAN MARTIN J · CIK 0001212813 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,468 Read SEC document |
| October 28, 2021 Filed Oct 29, 2021 01:20 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 249 | $218.27 | $54,348.48 |
DisclosureSEC source: 0001156375-21-000163 · wf-form4_163547043739369.xml · nonDerivative · entry 3 GEPSMAN MARTIN J · CIK 0001212813 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,968 Read SEC document |
| October 28, 2021 Filed Oct 29, 2021 01:20 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 104 | $218.29 | $22,702.16 |
DisclosureSEC source: 0001156375-21-000163 · wf-form4_163547043739369.xml · nonDerivative · entry 2 GEPSMAN MARTIN J · CIK 0001212813 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,217 Read SEC document |
| October 28, 2021 Filed Oct 29, 2021 01:20 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 147 | $218.24 | $32,081.28 |
DisclosureSEC source: 0001156375-21-000163 · wf-form4_163547043739369.xml · nonDerivative · entry 1 GEPSMAN MARTIN J · CIK 0001212813 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,321 Read SEC document |
| September 13, 2021 Filed Sep 13, 2021 23:37 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 1,000 | $188.54 | $188,535.00 |
DisclosureSEC source: 0001156375-21-000103 · wf-form4_163157623144073.xml · nonDerivative · entry 1 GEPSMAN MARTIN J · CIK 0001212813 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,468 Read SEC document |
| September 07, 2021 Filed Sep 8, 2021 14:40 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 1,000 | $194.25 | $194,250.00 |
DisclosureSEC source: 0001156375-21-000101 · wf-form4_163111199091821.xml · nonDerivative · entry 1 GEPSMAN MARTIN J · CIK 0001212813 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,468 Read SEC document |
| August 30, 2021 Filed Aug 31, 2021 01:10 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 885 | $201.00 | $177,885.00 |
DisclosureSEC source: 0001156375-21-000099 · wf-form4_163037223374142.xml · nonDerivative · entry 3 GEPSMAN MARTIN J · CIK 0001212813 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,468 Read SEC document |
| August 30, 2021 Filed Aug 31, 2021 01:10 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 15 | $201.02 | $3,015.30 |
DisclosureSEC source: 0001156375-21-000099 · wf-form4_163037223374142.xml · nonDerivative · entry 2 GEPSMAN MARTIN J · CIK 0001212813 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,353 Read SEC document |
| August 30, 2021 Filed Aug 31, 2021 01:10 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 100 | $201.03 | $20,103.00 |
DisclosureSEC source: 0001156375-21-000099 · wf-form4_163037223374142.xml · nonDerivative · entry 1 GEPSMAN MARTIN J · CIK 0001212813 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,368 Read SEC document |
| August 23, 2021 Filed Aug 24, 2021 02:00 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 1,000 | $201.37 | $201,365.00 |
DisclosureSEC source: 0001156375-21-000095 · wf-form4_162977039056310.xml · nonDerivative · entry 1 GEPSMAN MARTIN J · CIK 0001212813 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,468 Read SEC document |
| June 25, 2021 Filed Jun 30, 2021 00:21 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 551 | $218.12 | $120,184.12 |
DisclosureSEC source: 0001156375-21-000070 · edgardoc.xml · nonDerivative · entry 1 GEPSMAN MARTIN J · CIK 0001212813 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,468 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| March 11, 2021 Filed Mar 12, 2021 21:57 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 1,500 | $205.46 | $308,190.00 |
DisclosureSEC source: 0001156375-21-000026 · edgardoc.xml · nonDerivative · entry 1 GEPSMAN MARTIN J · CIK 0001212813 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,917 Read SEC document |
| December 14, 2020 Filed Dec 15, 2020 23:07 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 400 | $178.44 | $71,376.00 |
DisclosureSEC source: 0001156375-20-000128 · edgardoc.xml · nonDerivative · entry 1 GEPSMAN MARTIN J · CIK 0001212813 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,417 F1 · price: On December 14, 2020, Mr. Gepsman sold an aggregate of 400 shares of CME Group Class A common stock. For reporting purposes, the sale prices within a $1 range have been aggregated and the weighted average has been reported. The price ranges were $178.41 to $178.45. The Company maintains a record of the transactions and copies will be provided upon request. Read SEC document |
| December 01, 2020 Filed Dec 2, 2020 14:25 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 800 | $178.60 | $142,880.00 |
DisclosureSEC source: 0001156375-20-000123 · edgardoc.xml · nonDerivative · entry 1 GEPSMAN MARTIN J · CIK 0001212813 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,817 F1 · price: On December 1, 2020, Mr. Gepsman sold a total of 800 shares of CME Group Class A common stock at an average price of $178.60 per share. For reporting purposes, the sale prices within a $1 range have been aggregated and the weighted average has been reported. The price ranges were $178.57 through $178.64. The Company maintains a record of the transactions and copies will be provided upon request. Read SEC document |
| September 02, 2020 Filed Sep 3, 2020 19:23 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 5,000 | $173.52 | $867,600.00 |
DisclosureSEC source: 0001156375-20-000088 · edgardoc.xml · nonDerivative · entry 1 GEPSMAN MARTIN J · CIK 0001212813 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,617 Read SEC document |
| June 25, 2020 Filed Jun 29, 2020 22:10 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 712 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-20-000056 · edgardoc.xml · nonDerivative · entry 1 GEPSMAN MARTIN J · CIK 0001212813 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,617 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| January 03, 2020 Filed Jan 7, 2020 20:37 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 1,000 | $201.16 | $201,160.00 |
DisclosureSEC source: 0001156375-20-000001 · edgardoc.xml · nonDerivative · entry 1 GEPSMAN MARTIN J · CIK 0001212813 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,905 Read SEC document |
| June 25, 2019 Filed Jun 27, 2019 19:29 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 606 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-19-000062 · edgardoc.xml · nonDerivative · entry 1 GEPSMAN MARTIN J · CIK 0001212813 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,905 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 06, 2019 Filed Jun 10, 2019 19:04 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 2,500 | $201.21 | $503,025.00 |
DisclosureSEC source: 0001156375-19-000053 · edgardoc.xml · nonDerivative · entry 1 GEPSMAN MARTIN J · CIK 0001212813 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,299 Read SEC document |
| May 07, 2019 Filed May 9, 2019 16:17 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 2,000 | $178.07 | $356,140.00 |
DisclosureSEC source: 0001156375-19-000040 · edgardoc.xml · nonDerivative · entry 1 GEPSMAN MARTIN J · CIK 0001212813 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,799 Read SEC document |
| March 14, 2019 Filed Mar 18, 2019 20:54 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 3,000 | $167.91 | $503,730.00 |
DisclosureSEC source: 0001156375-19-000016 · primary_doc.xml · nonDerivative · entry 1 GEPSMAN MARTIN J · CIK 0001212813 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,799 Read SEC document |
| September 25, 2018 Filed Sep 27, 2018 21:08 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 87 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-18-000108 · edgardoc.xml · nonDerivative · entry 1 GEPSMAN MARTIN J · CIK 0001212813 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,799 F1 · shares: Incremental grant made pursuant to the CME Group Director Stock Plan, as amended and restated, as a result of an increase to Board compensation. Read SEC document |
| September 13, 2018 Filed Sep 14, 2018 21:11 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 200 | $172.30 | $34,460.00 |
DisclosureSEC source: 0001156375-18-000089 · edgardoc.xml · nonDerivative · entry 2 GEPSMAN MARTIN J · CIK 0001212813 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,712 Read SEC document |
| September 13, 2018 Filed Sep 14, 2018 21:11 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 100 | $172.29 | $17,229.00 |
DisclosureSEC source: 0001156375-18-000089 · edgardoc.xml · nonDerivative · entry 1 GEPSMAN MARTIN J · CIK 0001212813 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,912 Read SEC document |
| June 25, 2018 Filed Jun 27, 2018 17:40 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 601 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-18-000062 · edgardoc.xml · nonDerivative · entry 1 GEPSMAN MARTIN J · CIK 0001212813 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,012 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| May 25, 2018 Filed May 29, 2018 21:04 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 600 | $159.77 | $95,862.00 |
DisclosureSEC source: 0001156375-18-000051 · edgardoc.xml · nonDerivative · entry 1 GEPSMAN MARTIN J · CIK 0001212813 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,411 Read SEC document |
| February 15, 2018 Filed Feb 16, 2018 15:08 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 300 | $164.29 | $49,287.00 |
DisclosureSEC source: 0001156375-18-000022 · edgardoc.xml · nonDerivative · entry 1 GEPSMAN MARTIN J · CIK 0001212813 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,011 Read SEC document |
| August 09, 2017 Filed Aug 11, 2017 16:12 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 200 | $126.14 | $25,228.00 |
DisclosureSEC source: 0001156375-17-000085 · edgardoc.xml · nonDerivative · entry 1 GEPSMAN MARTIN J · CIK 0001212813 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,311 Read SEC document |
| June 26, 2017 Filed Jun 27, 2017 22:00 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 809 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-17-000070 · edgardoc.xml · nonDerivative · entry 1 GEPSMAN MARTIN J · CIK 0001212813 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,511 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| December 09, 2016 Filed Dec 13, 2016 22:21 UTC | CME GROUP INC. CME · Entity 2909 | OtherCommon Stock Class A | 100 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-16-000263 · edgardoc.xml · nonDerivative · entry 1 GEPSMAN MARTIN J · CIK 0001212813 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,702 F1 · kind: Mr. Gepsman shared joint ownership of 495 shares of Class A common stock and of one share of Class B-4 common stock with two other members of the Chicago Mercantile Exchange Inc. On December 9, 2016, in consideration for receiving the partial ownership interest in the share of Class B-4 common stock from one of the other owners, Mr. Gepsman transferred to such individual 100 out of the 495 shares of Class A common stock that were jointly held. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.